Literature DB >> 32772560

Systemic adjuvant treatment in hepatocellular carcinoma: tempted to do something rather than nothing.

Alessandro Rizzo1, Angela Dalia Ricci1, Giovanni Brandi1.   

Abstract

Entities:  

Keywords:  HCC; adjuvant therapy; adjuvant treatment; hepatocellular carcinoma; immunotherapy; liver cancer

Year:  2020        PMID： 32772560     DOI： 10.2217/fon-2020-0669

Source DB:  PubMed          Journal:  Future Oncol        ISSN： 1479-6694            Impact factor:   3.404


× No keyword cloud information.
  4 in total

1.  Adjuvant Therapy With PD1/PDL1 Inhibitors for Human Cancers: A Systematic Review and Meta-Analysis.

Authors:  Yao Jin; Jiayan Wei; Yiming Weng; Jia Feng; Zexi Xu; Peiwei Wang; Xue Cui; Xinyi Chen; Jinsong Wang; Min Peng
Journal:  Front Oncol       Date:  2022-02-25       Impact factor: 6.244

Review 2.  Efficacy and safety of monotherapy and combination therapy of immune checkpoint inhibitors as first-line treatment for unresectable hepatocellular carcinoma: a systematic review, meta-analysis and network meta-analysis.

Authors:  Qing Lei; Xin Yan; Huimin Zou; Yixuan Jiang; Yunfeng Lai; Carolina Oi Lam Ung; Hao Hu
Journal:  Discov Oncol       Date:  2022-09-28

Review 3.  Advances and challenges of immunocheckpoint inhibitors in the treatment of primary liver cancer.

Authors:  Meng Hu; Weirong Yao; Qinglin Shen
Journal:  Front Genet       Date:  2022-09-30       Impact factor: 4.772

4.  Establishment and Evaluation of a Predictive Model for Early Postoperative Recurrence of Hepatocellular Carcinoma in Patients with Microvascular Invasion.

Authors:  Kai Zhang; Changcheng Tao; Fan Wu; Tana Siqin; Jianxiong Wu; Weiqi Rong
Journal:  Int J Gen Med       Date:  2021-06-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.